Economic evaluation of personalized medicine: a call for real-world data
- PMID: 28382502
- DOI: 10.1007/s10198-017-0890-x
Economic evaluation of personalized medicine: a call for real-world data
Similar articles
-
Conducting economic evaluation based on basket clinical trial in the area of precision medicine.Expert Rev Pharmacoecon Outcomes Res. 2021 Apr;21(2):169-171. doi: 10.1080/14737167.2021.1865158. Epub 2020 Dec 24. Expert Rev Pharmacoecon Outcomes Res. 2021. PMID: 33356657 No abstract available.
-
Some economics on personalized and predictive medicine.Eur J Health Econ. 2015 Dec;16(9):985-94. doi: 10.1007/s10198-014-0647-8. Epub 2014 Nov 8. Eur J Health Econ. 2015. PMID: 25381039
-
H2020 and Beyond: Skip Discrepancy between Theory and Practice of Personalized Medicine. A Position Paper by the Italian Society of Personalized Medicine.Curr Pharm Biotechnol. 2016;17(10):926-9. doi: 10.2174/1389201017666160519112850. Curr Pharm Biotechnol. 2016. PMID: 27194357
-
A review of international coverage and pricing strategies for personalized medicine and orphan drugs.Health Policy. 2017 Dec;121(12):1240-1248. doi: 10.1016/j.healthpol.2017.09.005. Epub 2017 Sep 29. Health Policy. 2017. PMID: 29033060 Review.
-
Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?Pharmacogenomics J. 2017 Oct;17(5):395-402. doi: 10.1038/tpj.2017.21. Epub 2017 Jun 13. Pharmacogenomics J. 2017. PMID: 28607506 Free PMC article. Review.
Cited by
-
Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis.Front Pharmacol. 2021 Oct 19;12:700012. doi: 10.3389/fphar.2021.700012. eCollection 2021. Front Pharmacol. 2021. PMID: 34737696 Free PMC article.
-
Economic Evaluations Informed Exclusively by Real World Data: A Systematic Review.Int J Environ Res Public Health. 2020 Feb 12;17(4):1171. doi: 10.3390/ijerph17041171. Int J Environ Res Public Health. 2020. PMID: 32059593 Free PMC article.
-
Economic evaluation of germline genetic testing for breast cancer in low- and middle-income countries: a systematic review.BMC Cancer. 2024 Mar 7;24(1):316. doi: 10.1186/s12885-024-12038-7. BMC Cancer. 2024. PMID: 38454347 Free PMC article.
-
Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review.Eur J Haematol. 2022 Jun;108(6):469-485. doi: 10.1111/ejh.13755. Epub 2022 Mar 2. Eur J Haematol. 2022. PMID: 35158410 Free PMC article.
-
Regulated Pricing Decisions and Diagnostic Test Choices in Personalized Medicine: Navigating the Implications Within Legal Frameworks.Risk Manag Healthc Policy. 2024 Nov 9;17:2763-2776. doi: 10.2147/RMHP.S475929. eCollection 2024. Risk Manag Healthc Policy. 2024. PMID: 39544252 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous